Bionano Genomics company info

What does Bionano Genomics do?
Bionano Genomics (NASDAQ:BNGO) specializes in offering tools and services based on its Saphyr system for the analysis of chromosomes, known as cytogenomics. This technology provides researchers and clinicians with a deeper understanding of genetics and the structure of the genome, aiding in the detection of diseases and disorders that conventional cytogenetics might miss. Focused on revolutionizing the way genomic research is conducted, Bionano aims to unlock critical genomic information with high-throughput and high-resolution capabilities. The company is dedicated to advancing the field of genomics, striving to make its cutting-edge technology an integral part of research and clinical diagnostics. By pushing the boundaries of genomic analysis, Bionano's objective is to contribute to the development of personalized medicine and improve healthcare outcomes.
Bionano Genomics company media
Company Snapshot

Is Bionano Genomics a public or private company?

key
Ownership
Public

How many people does Bionano Genomics employ?

people
Employees
344

What sector is Bionano Genomics in?

pie chart
Sector
Health Care

Where is the head office for Bionano Genomics?

location pin
Head Office
San Diego, United States

What year was Bionano Genomics founded?

founded flag
Year Founded
2003
What does Bionano Genomics specialise in?
/Genomic Mapping /Saphyr System /Bioinformatics Platform /Genome Imaging /Diagnostic Services /Research Tools

What are the products and/or services of Bionano Genomics?

Overview of Bionano Genomics offerings
Saphyr System: A genome imaging tool for high-throughput chromosomal conformation capture, providing insights into structural variations and complex rearrangements.
Preclinical Research Services: Offering genome analysis services, leveraging the Saphyr system for genetic disease research and drug development.
Bionano Prep Kits: Consumables tailored for the Saphyr system, enabling efficient sample preparation for genome imaging.
Data Analysis Services: Providing comprehensive genome data analysis, interpretation, and reporting services to accelerate research findings.

Who is in the executive team of Bionano Genomics?

Bionano Genomics leadership team
  • Dr. Robert Erik Holmlin M.B.A., Ph.D.
    Dr. Robert Erik Holmlin M.B.A., Ph.D.
    President, CEO, Secretary & Director
  • Mr. Mark  Oldakowski
    Mr. Mark Oldakowski
    Chief Operating Officer
  • Dr. Alka  Chaubey FACMG, Ph.D.
    Dr. Alka Chaubey FACMG, Ph.D.
    Chief Medical Officer
  • Ms. Gulsen  Kama M.B.A.
    Ms. Gulsen Kama M.B.A.
    Chief Financial Officer
  • Mr. Mark  Adamchak CPA
    Mr. Mark Adamchak CPA
    VP of Accounting & Controller
  • Mr. Jonathan  Dixon J.D.
    Mr. Jonathan Dixon J.D.
    General Counsel
  • Mr. Stanislas  Marin M.B.A., M.S.
    Mr. Stanislas Marin M.B.A., M.S.
    Vice President of Global Sales
  • Ms. Donna  Polizio
    Ms. Donna Polizio
    Global Head of Market Access